YPR142C Antibody

What is the YPR142C protein and why is it studied?

YPR142C is a putative uncharacterized protein in yeast with a sequence length of 187 amino acids . Despite being uncharacterized, studying this protein through antibody-based techniques is valuable for advancing our understanding of yeast proteomics and potentially revealing novel functions within yeast cellular pathways. The protein's study contributes to the broader field of functional genomics, where researchers aim to identify the roles of previously uncharacterized proteins. Methodologically, researchers typically employ techniques such as immunoprecipitation, Western blotting, and immunofluorescence with anti-YPR142C antibodies to investigate its expression patterns, localization, and potential binding partners.

What are the structural characteristics of the YPR142C protein?

The YPR142C protein consists of 187 amino acids with the following sequence: MMGSFLSYAFRCDDKIAFTAAENPVEPSSCLLFFDFFFLGKSSSSSSSSSSSSASLCSLSIILDDSSLELFCSSSSASSPSIIVSFSGSLLNSWLPLFLFSRPNSAFFLVLFLSLVSTLCLEPMINYVLIFLRLLYRFIHSICLLPFLISYGHRILDFFLSKFSNKRVMEIHQNESQTKSKQTLFTI . This sequence indicates a protein with multiple serine-rich regions and hydrophobic domains that may suggest membrane association. When designing experimental approaches, researchers should consider these structural features, particularly when selecting antibody epitopes for detection. For immunodetection experiments, it's advisable to use antibodies targeting different regions of the protein to compare results and confirm specificity.

What types of anti-YPR142C antibodies are available for research?

Currently, there are three main types of anti-YPR142C antibody preparations available for research, each targeting different regions of the protein:

All three antibody preparations have similar ELISA titers (approximately 10,000), corresponding to the ability to detect approximately 1 ng of target protein on Western blots . The selection of the appropriate antibody preparation should be based on the experimental question and the accessibility of the target epitope under your specific experimental conditions.

How should I validate an anti-YPR142C antibody before using it in my experiments?

Proper validation of anti-YPR142C antibodies is crucial for ensuring reliable experimental results. Based on current best practices in antibody validation, you should implement the following methodological approach:

• Knockout/knockdown control testing: Generate YPR142C knockout or knockdown yeast strains and compare antibody reactivity between wild-type and modified strains. According to research on antibody characterization, knockout controls are superior to other validation methods, particularly for Western blots and immunofluorescence imaging .

• Orthogonal validation: Compare protein expression data from antibody-based detection with mRNA expression data or mass spectrometry results.

• Independent antibody validation: Test multiple antibodies targeting different epitopes of YPR142C (e.g., N-terminus, C-terminus, and middle region) and compare results .

• Positive and negative control samples: Include positive controls (samples known to express YPR142C) and negative controls (samples known not to express the protein).

• Specificity testing: Perform peptide competition assays where the antibody is pre-incubated with the immunizing peptide before application to test samples.

Documentation of these validation steps should be maintained and reported in publications to enhance reproducibility and reliability of research findings.

What are the key differences between monoclonal, polyclonal, and recombinant antibodies for YPR142C research?

While the commercially available anti-YPR142C antibodies are combinations of monoclonal antibodies , understanding the differences between antibody types is important for experimental design:

Recent studies have demonstrated that recombinant antibodies outperform both monoclonal and polyclonal antibodies across multiple assay types . For YPR142C research, considering the development of recombinant antibodies may provide more consistent and reliable results, especially for long-term research projects where antibody consistency is crucial.

How can I determine the optimal antibody concentration for my specific experimental setup?

Determining the optimal antibody concentration requires systematic titration experiments. Follow this methodological approach:

• Initial range finding: Start with the manufacturer's recommended dilution range (typically 1:1000 to 1:5000 for Western blots).

• Systematic titration: Prepare a series of dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000, 1:10000) of the antibody.

• Signal-to-noise optimization: For each dilution, analyze both the specific signal (from samples expressing YPR142C) and background signal (from negative controls).

• Quantitative assessment: Calculate signal-to-noise ratios for each concentration and select the dilution that provides the highest ratio.

• Reproducibility testing: Verify that the selected concentration provides consistent results across multiple experimental replicates.

This approach ensures you are using the minimum antibody concentration that provides reliable detection, optimizing both experimental quality and resource utilization.

What are the best practices for using anti-YPR142C antibodies in Western blot experiments?

For optimal Western blot results with anti-YPR142C antibodies, implement the following methodological protocol:

• Sample preparation:

  • Use appropriate lysis buffers with protease inhibitors to prevent degradation

  • Include phosphatase inhibitors if investigating potential phosphorylation states

  • Standardize protein concentration (typically 20-50 μg total protein per lane)

• Controls:

  • Include both positive and negative controls

  • Ideally, use YPR142C knockout/knockdown samples as negative controls

  • Consider including recombinant YPR142C protein as a positive control

• Electrophoresis and transfer:

  • Select appropriate percentage gels based on YPR142C's molecular weight (187 amino acids)

  • Optimize transfer conditions for proteins of this size

• Antibody incubation:

  • Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Incubate with primary anti-YPR142C antibody overnight at 4°C using optimized dilution

  • Wash thoroughly with TBST (3-5 times, 5-10 minutes each)

  • Incubate with appropriate secondary antibody for 1 hour at room temperature

  • Wash thoroughly again with TBST

• Detection and analysis:

  • Use appropriate detection methods based on experimental needs (chemiluminescence, fluorescence)

  • Quantify bands using appropriate software, normalizing to loading controls

Remember that the available anti-YPR142C antibodies have an ELISA titer of approximately 10,000, corresponding to detection sensitivity of approximately 1 ng on Western blots .

How can I optimize immunoprecipitation experiments using anti-YPR142C antibodies?

Successful immunoprecipitation (IP) of YPR142C requires careful optimization of multiple parameters. Follow this methodological workflow:

• Buffer optimization:

  • Test different lysis buffers to identify conditions that maintain protein-protein interactions while efficiently extracting YPR142C

  • Consider both nonionic (e.g., NP-40, Triton X-100) and ionic detergents depending on subcellular localization

  • Include appropriate protease and phosphatase inhibitors

• Antibody selection and coupling:

  • Test all three available antibody preparations (N-terminus, C-terminus, middle region) to identify which best captures native YPR142C

  • Compare direct antibody addition versus pre-coupling to beads (Protein A/G or magnetic)

  • Determine optimal antibody amounts through titration experiments

• IP conditions:

  • Optimize incubation time and temperature (typically 1-4 hours at 4°C)

  • Determine appropriate wash stringency to minimize non-specific binding

  • Evaluate elution methods (denaturing vs. native) based on downstream applications

• Validation controls:

  • Perform parallel IPs with non-specific antibodies of the same isotype

  • Include knockout/knockdown samples as negative controls

  • Consider reciprocal IP with antibodies to known interacting partners

• Analysis methods:

  • Verify IP efficiency by comparing input, supernatant, and IP fractions

  • Identify co-immunoprecipitated proteins using mass spectrometry or specific antibodies

By systematically optimizing these parameters, you can establish robust IP protocols for investigating YPR142C protein interactions.

What considerations should be made when designing immunofluorescence experiments with anti-YPR142C antibodies?

Immunofluorescence experiments require additional considerations to ensure specific and sensitive detection of YPR142C. Follow these methodological guidelines:

• Fixation optimization:

  • Compare different fixation methods (paraformaldehyde, methanol, acetone) to determine which best preserves YPR142C epitopes

  • Optimize fixation time and temperature for yeast cells

• Permeabilization conditions:

  • Test different permeabilization agents (Triton X-100, saponin, digitonin) and concentrations

  • Balance sufficient permeabilization for antibody access with preservation of cellular structures

• Antibody selection and validation:

  • Test all three available antibody preparations to identify which provides the most specific signal

  • Include appropriate controls, particularly YPR142C knockout/knockdown samples, as knockout controls are especially important for immunofluorescence validation

• Blocking optimization:

  • Test different blocking solutions (BSA, normal serum, commercial blockers)

  • Optimize blocking time and temperature

• Signal detection and analysis:

  • Use appropriate fluorophore-conjugated secondary antibodies

  • Include nuclear and organelle markers for co-localization studies

  • Employ high-resolution imaging techniques if studying suborganelle localization

  • Perform quantitative analysis using appropriate software

Recent research has emphasized that knockout controls are even more critical for immunofluorescence than for Western blots due to the increased potential for non-specific binding in preserved cellular contexts .

How can I address specificity issues with anti-YPR142C antibodies in my experiments?

Addressing specificity issues requires a systematic troubleshooting approach:

• Validate antibody specificity with controls:

  • Use YPR142C knockout/knockdown samples as negative controls

  • Recent research shows that ~12 publications per protein target included data from antibodies that failed to recognize their intended target , highlighting the importance of proper validation

• Epitope mapping and blocking studies:

  • Perform peptide competition assays using the immunizing peptides

  • Compare results from antibodies targeting different regions of YPR142C

• Cross-reactivity assessment:

  • Test antibody reactivity against closely related proteins

  • Perform database searches to identify proteins with similar epitopes

• Optimization of experimental conditions:

  • Adjust antibody dilution to minimize non-specific binding

  • Optimize washing steps (increase number, duration, or stringency)

  • Test different blocking agents (BSA, casein, normal serum)

• Consider alternative detection methods:

  • Compare results with orthogonal techniques (e.g., mass spectrometry)

  • Consider using tagged versions of YPR142C with well-validated tag antibodies

Properly addressing specificity issues is critical, as it has been estimated that ~50% of commercial antibodies fail to meet basic standards for characterization .

What approaches can be used to study post-translational modifications of YPR142C?

Investigating potential post-translational modifications (PTMs) of YPR142C requires specialized approaches:

• Phosphorylation analysis:

  • Use phosphatase inhibitors during sample preparation

  • Employ phospho-specific antibodies if available, or general phospho-amino acid antibodies

  • Consider enrichment strategies like phosphopeptide enrichment followed by mass spectrometry

  • Use Phos-tag gels to separate phosphorylated from non-phosphorylated forms

• Ubiquitination studies:

  • Include deubiquitinase inhibitors in lysis buffers

  • Perform immunoprecipitation with anti-YPR142C antibodies followed by ubiquitin Western blotting

  • Consider expressing tagged ubiquitin for enhanced detection

• Other PTM investigations:

  • For glycosylation: Use glycosidase treatments followed by Western blotting

  • For SUMOylation: Employ SUMO-specific antibodies after YPR142C immunoprecipitation

  • For acetylation: Use anti-acetyl lysine antibodies after immunoprecipitation

• Mass spectrometry approaches:

  • Immunoprecipitate YPR142C using validated antibodies

  • Perform tryptic digestion followed by LC-MS/MS

  • Use specialized software to identify PTM sites and quantify modification levels

• Functional validation:

  • Generate mutants at identified PTM sites

  • Assess effects on protein function, localization, stability, and interactions

These approaches will provide comprehensive insights into the post-translational regulation of YPR142C.

How can I develop a quantitative assay for measuring YPR142C protein levels in different conditions?

Developing a quantitative assay for YPR142C requires careful consideration of multiple factors:

• Assay platform selection:

  • Quantitative Western blot: Suitable for moderate-throughput analysis

  • ELISA: Higher throughput with potentially greater sensitivity

  • Flow cytometry: For single-cell analysis if studying cell-to-cell variation

  • Mass spectrometry: For absolute quantification using isotope-labeled standards

• Calibration strategy:

  • Generate recombinant YPR142C standards of known concentration

  • Create a standard curve covering the expected physiological range

  • Include these standards in each experimental run

• Antibody optimization:

  • Determine the linear range of detection for each antibody preparation

  • Select the antibody with the widest linear range and highest specificity

  • For sandwich assays, use antibodies targeting different epitopes

• Sample preparation standardization:

  • Develop consistent extraction protocols

  • Include internal controls for normalization

  • Consider spike-in controls to assess extraction efficiency

• Validation and quality control:

  • Assess assay precision through replicate analysis

  • Determine limits of detection and quantification

  • Evaluate assay robustness across different sample types

  • Compare results with orthogonal methods (e.g., mass spectrometry)

The available anti-YPR142C antibodies with ELISA titers of approximately 10,000 should provide sufficient sensitivity for most applications, but the specific detection limits will need to be determined empirically for each experimental system.

What are the current limitations in YPR142C antibody research and potential future developments?

Current limitations and future directions in YPR142C antibody research include:

• Current limitations:

  • Limited characterization of the YPR142C protein itself

  • Potential specificity issues with available antibodies, as approximately 50% of commercial antibodies fail to meet basic characterization standards

  • Lack of validated applications beyond ELISA and Western blotting for current antibodies

  • Limited knowledge of YPR142C's physiological roles and regulation

• Emerging technologies:

  • Development of recombinant antibodies, which recent research shows outperform both monoclonal and polyclonal antibodies

  • Single-domain antibodies (nanobodies) for improved access to conformational epitopes

  • Antibody engineering platforms that don't require animal immunization, such as yeast-displayed antibody libraries

  • CRISPR-based tagging approaches as alternatives to antibody-based detection

• Methodological advances:

  • Improved antibody validation strategies using knockout controls

  • Development of multiplex detection systems for studying YPR142C in context with interacting proteins

  • Advanced imaging techniques for studying subcellular localization at higher resolution

• Future research directions:

  • Comprehensive characterization of YPR142C function and regulation

  • Development of conditional systems to study YPR142C dynamics

  • Integration of antibody-based methods with other -omics approaches for systems-level analysis

The recent development of animal-free antibody production methods, such as yeast-displayed antibody libraries , may enable more rapid and ethical development of highly specific anti-YPR142C antibodies in the future.

How can I use anti-YPR142C antibodies in conjunction with CRISPR-Cas9 genome editing?

Integrating anti-YPR142C antibodies with CRISPR-Cas9 approaches provides powerful tools for functional studies:

• Validation of CRISPR editing:

  • Use anti-YPR142C antibodies to confirm successful knockout at the protein level

  • Quantify knockdown efficiency in partial knockout populations

  • Compare different guide RNA efficacies based on remaining protein levels

• Tagging strategies:

  • Design CRISPR knock-in strategies to add epitope tags to YPR142C

  • Compare detection with anti-tag antibodies versus anti-YPR142C antibodies

  • Use proximity labeling approaches (BioID, APEX) with YPR142C as the bait protein

• Functional domain analysis:

  • Generate domain deletion mutants using CRISPR

  • Use region-specific antibodies to verify truncation and study remaining fragments

  • Correlate structural changes with functional outcomes

• Combinatorial approaches:

  • Perform CRISPR screens for genes that interact with YPR142C

  • Use antibodies to assess how these interactions affect YPR142C levels, modifications, or localization

  • Develop reporter assays incorporating antibody-based detection methods

These integrated approaches will provide deeper insights into YPR142C function and regulation than either technique alone could achieve.

What strategies can be employed for studying protein-protein interactions involving YPR142C?

Investigating YPR142C protein interactions requires a multi-technique approach:

• Co-immunoprecipitation strategies:

  • Use different anti-YPR142C antibodies to pull down protein complexes

  • Compare native versus crosslinking conditions to capture transient interactions

  • Analyze co-precipitated proteins by mass spectrometry or Western blotting

• Proximity labeling approaches:

  • Generate fusion proteins of YPR142C with BioID, APEX, or TurboID

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

  • Validate key interactions using anti-YPR142C antibodies

• Fluorescence-based interaction assays:

  • Perform Förster Resonance Energy Transfer (FRET) or Bimolecular Fluorescence Complementation (BiFC)

  • Use antibodies for validation and quantification of expression levels

  • Develop high-content screening approaches for interaction modulators

• Yeast two-hybrid and split-reporter systems:

  • Use these systems for initial interaction screening

  • Validate hits with antibody-based methods in native contexts

  • Combine with domain mapping to identify interaction interfaces

• In vitro interaction assays:

  • Express recombinant YPR142C and potential partners

  • Perform pulldown assays, surface plasmon resonance, or isothermal titration calorimetry

  • Use antibodies to detect and quantify binding

These complementary approaches will generate a comprehensive map of YPR142C interactions within the cellular environment.

How can new antibody technologies like nanobodies be applied to YPR142C research?

Emerging nanobody technologies offer several advantages for YPR142C research:

• Benefits of nanobodies for YPR142C studies:

  • Smaller size (15 kDa vs. 150 kDa for conventional antibodies) allows access to sterically hindered epitopes

  • Greater stability in different buffer conditions

  • Potential for intracellular expression as functional intrabodies

  • Single-domain nature simplifies engineering and modification

• Generation strategies:

  • Traditional llama/alpaca immunization followed by phage display

  • Newer animal-free methods using synthetic yeast libraries, similar to the approach described for other proteins

  • The yeast-based system developed by Harvard researchers could generate nanobodies in 3-6 weeks rather than 3-6 months

• Applications in YPR142C research:

  • Super-resolution microscopy using directly-labeled nanobodies

  • Intracellular tracking of YPR142C in living cells

  • Conformation-specific detection of structural states

  • Targeted protein degradation using nanobody-based degraders

• Integration with other technologies:

  • Combination with optogenetic tools for light-controlled perturbation

  • Development of nanobody-based biosensors for real-time activity monitoring

  • Use in cryo-EM studies to stabilize specific conformations

Recent advances in yeast-displayed nanobody libraries, which contain approximately 500 million unique antibodies , provide promising platforms for developing highly specific YPR142C nanobodies without animal immunization.

How can I interpret contradictory results obtained with different anti-YPR142C antibodies?

Resolving contradictory results requires systematic investigation:

• Antibody characterization assessment:

  • Review validation data for each antibody

  • Determine which epitopes each antibody recognizes

  • Assess potential for differential detection of protein isoforms or modified forms

• Methodological considerations:

  • Compare experimental conditions (fixation methods, buffer compositions, detection systems)

  • Evaluate whether contradictions are technique-specific

  • Consider whether sample preparation might differentially affect epitope accessibility

• Biological interpretations:

  • Investigate whether discrepancies might reflect biologically relevant differences

  • Consider potential post-translational modifications that might affect antibody recognition

  • Evaluate whether protein conformation or complex formation might mask epitopes

• Resolution strategies:

  • Perform side-by-side comparisons using identical samples and protocols

  • Include appropriate positive and negative controls, particularly YPR142C knockout samples

  • Employ orthogonal detection methods (mass spectrometry, genetic tagging)

  • Consider epitope mapping to precisely define what each antibody recognizes

Recent research has highlighted that approximately 12 publications per protein target included data from antibodies that failed to recognize the relevant target protein , underscoring the importance of thorough validation when contradictory results are observed.